Cargando…
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Parkinson's disease (PD) affects at least 6.5 million people worldwide, irrespective of gender, social, ethnic, economic, or geographic boundaries. Key symptoms, such as tremor, rigidity and bradikinesia, develop when about 3/4 of dopaminergic cells are lost in the substantia nigra, and fail to...
Autores principales: | da Conceição, Fabio S.L., Ngo-Abdalla, Stacie, Houzel, Jean-Christophe, Rehen, Stevens K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841569/ https://www.ncbi.nlm.nih.gov/pubmed/20081770 http://dx.doi.org/10.3791/1376 |
Ejemplares similares
-
Neuroprotective Effect of Intrastriatal Caffeic Acid Phenethyl Ester Treatment in 6-OH Dopamine Model of Parkinson's Disease in Rats
por: Soner, Burak Cem, et al.
Publicado: (2021) -
Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson’s disease
por: Acquarone, Mariana, et al.
Publicado: (2015) -
Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017) -
Habitual behavior and dopamine cell vulnerability in Parkinson disease
por: Hernández, Ledia F., et al.
Publicado: (2015) -
Dopamine Transporter Loss in 6-OHDA Parkinson’s Model Is Unmet by Parallel Reduction in Dopamine Uptake
por: Chotibut, Tanya, et al.
Publicado: (2012)